China Health Group Limited (carrying on business in Hong Kong as CHG HS Limited) filed its Monthly Return for the period ended 31 July 2026, confirming no movements in authorised, issued or treasury shares during the month and affirming continued compliance with Hong Kong Stock Exchange public-float requirements.

Authorised Share Capital • Ordinary shares: 100.00 billion shares with a par value of HKD 0.10 each, representing authorised capital of HKD 10.00 billion; no change from June 2026. • Redeemable Convertible Cumulative Preference Shares: 15,000 shares at USD 0.01 each (equivalent to HKD 1,164); unchanged.

Issued and Treasury Shares • Issued ordinary shares stood at 1.39 billion, with zero treasury shares both at the beginning and end of July, indicating no new issuance, cancellation, or buy-back activity. • The company confirmed adherence to the minimum 25% public-float threshold as required under Main Board Rule 13.32B.

Equity Incentives • Share Option Scheme (approved 28 August 2012): 20.84 million options remained outstanding. • No options were exercised, no new shares were issued, and no treasury shares were transferred during the month, leaving potential dilution unchanged.

Other Equity Instruments • The company reported no outstanding or newly issued warrants, convertible securities, or other share-linked agreements in July.

Regulatory Compliance Director Cao Xu certified that all securities matters for the period complied with Hong Kong listing rules and related regulatory obligations, and that all requisite filings and conditions have been duly satisfied.